CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-11-13 | Labinger Barry EVP, Biosciences Div. | Sale | −3,376 | $36.50 | $123K | 25,182 |
| 2015-11-13 | El-Hibri Fuad Chairman | Exercise or conversion | +20,000 | $18.90 | $378K | 1,855,268 |
| 2015-11-13 | El-Hibri Fuad Chairman | Sale | −13,013 | $36.50 | $475K | 1,842,255 |
| 2015-11-13 | El-Hibri Fuad Chairman | Exercise or conversion · Employee Stock Option | −20,000 | 27,900 | ||
| 2015-11-12 | Labinger Barry EVP, Biosciences Div. | Exercise or conversion | +10,094 | $20.94 | $211K | 40,323 |
| 2015-11-12 | Labinger Barry EVP, Biosciences Div. | Sale | −10,094 | $36.00 | $363K | 30,229 |
| 2015-11-12 | Labinger Barry EVP, Biosciences Div. | Exercise or conversion · Stock Option | −10,094 | 0 | ||
| 2015-11-11 | Labinger Barry EVP, Biosciences Div. | Sale | −6,564 | $35.51 | $233K | 30,229 |
| 2015-11-11 | Labinger Barry EVP, Biosciences Div. | Exercise or conversion | +9,373 | $28.09 | $263K | 39,602 |
| 2015-11-11 | Labinger Barry EVP, Biosciences Div. | Sale | −9,373 | $35.50 | $333K | 30,229 |
| 2015-11-11 | Labinger Barry EVP, Biosciences Div. | Exercise or conversion | +10,095 | $20.94 | $211K | 40,324 |
| 2015-11-11 | Labinger Barry EVP, Biosciences Div. | Sale | −10,095 | $35.50 | $358K | 30,229 |
| 2015-11-11 | Labinger Barry EVP, Biosciences Div. | Shares withheld for taxes | −1,671 | $35.88 | $60K | 28,558 |
| 2015-11-11 | Labinger Barry EVP, Biosciences Div. | Exercise or conversion · Stock Option | −9,373 | 0 | ||
| 2015-11-11 | Labinger Barry EVP, Biosciences Div. | Exercise or conversion · Stock Option | −10,095 | 0 | ||
| 2015-11-09 | El-Hibri Fuad Chairman | Exercise or conversion | +20,000 | $18.90 | $378K | 1,848,493 |
| 2015-11-09 | El-Hibri Fuad Chairman | Sale | −13,225 | $35.50 | $469K | 1,835,268 |
| 2015-11-09 | El-Hibri Fuad Chairman | Exercise or conversion · Employee Stock Option | −20,000 | 47,900 | ||
| 2015-11-06 | El-Hibri Fuad Chairman | Exercise or conversion | +20,000 | $18.90 | $378K | 1,841,943 |
| 2015-11-06 | El-Hibri Fuad Chairman | Sale | −13,450 | $34.50 | $464K | 1,828,493 |
Page 62 of 65 · 1,282 trades